IL Therapeutics Inc. was previously owned by Western Life Sciences Venture Fund LP ("Western Life Sciences") and in 2006 its shares were purchased by...

Financial Financials Asset managers Winnipeg 1926 Asset management IL Therapeutics Health care Biotechnology Saskatoon 2005 Bio-tech IMAX Corporation...

Plasma Resources Guardian Biotechnologies Great Western Brewing Company IL Therapeutics Prairie Plant Systems Robin Hood Flour Affinity Credit Union First...

operations. In September 2022, Roche acquired Good Therapeutics at a cost of $250M for its PD1-regulated IL-2 receptor agonist program. In July 2023, Roche...

Swiss NBE-Therapeutics on the development of novel antibody-drug conjugate products (ADC), with its affiliate Cytune Pharma on developing novel IL-15-based...

Topokine Therapeutics (Acq 2016) Vitae Pharmaceuticals, Inc (Acq 2016) Tobira Therapeutics (Acq 2016) ForSight VISION5 (Acq 2016) RetroSense Therapeutics (Acq...

proliferate CD8+ T cells and NK cells. It is being developed by Nektar Therapeutics. In August 2019 the FDA granted breakthrough therapy designation to bempegaldesleukin...

org. Retrieved 2021-06-22. Therapeutics, Neoleukin (June 2020). "NL-201: A de novo CD25-independent combined IL-2 and IL-15 receptor agonistdesigned...

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial...

Anti-interleukin-6 agents are a class of therapeutics. Interleukin 6 is a cytokine relevant to many inflammatory diseases and many cancers. Hence, anti-IL6...

Pharmaceuticals and its RNAi therapeutics, for $3.3 billion ($38.25 per share). In September 2022, Novo agreed to acquire Forma Therapeutics for $1.1 billion with...

companies, these include Guardian Biotechnologies, Prairie Plant Systems, IL Therapeutics among others. Most major Canadian banks and financial services companies...

factors such as TGF beta, VEGF, and PDGF Cytokines such as IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-9, IL-13, and TNF alpha There are also eosinophils that play...

Hospira are located in Lake Forest; Akorn, Covered Logistics, Horizon Therapeutics, IDEX, Packaging Corporation of America, Pactiv, Prestone, and Trustmark...

December 2014). "Treatment of adult-onset Still's disease: a review". Therapeutics and Clinical Risk Management. 11: 33–43. doi:10.2147/TCRM.S64951. PMC 4278737...

"Diuretics: a review and update". Journal of Cardiovascular Pharmacology and Therapeutics. 19 (1): 5–13. doi:10.1177/1074248413497257. PMID 24243991. S2CID 21204143...

which include IL-2, IL-4, IL-6, IL-13, and IL-31 (TSLP, another pruritogenic cytokine that uses JAKs, has also been found to be inhibited). IL-31 is a key...

(2016). "Secukinumab for ankylosing spondylitis and psoriatic arthritis". Therapeutics and Clinical Risk Management. 12: 1587–1592. doi:10.2147/TCRM.S100091...

novel antibody treatment (bermekimab) that neutralizes interleukin-1 alpha (IL-1⍺) to Janssen Biotech, Inc. On 27 March 2020, the U.S. Biomedical Advanced...

Hyper-IL-6 is a designer cytokine, which was generated by the German biochemist Stefan Rose-John. Hyper-IL-6 is a fusion protein of the four-helical cytokine...

intravenously in postaddicts". The Journal of Pharmacology and Experimental Therapeutics. 133: 388–99. PMID 13767429. National Institute on Drug Abuse (NIDA)...

non-erosive gastro-oesophageal reflux disease". Alimentary Pharmacology & Therapeutics. 21 (Suppl 2): 10–8. doi:10.1111/j.1365-2036.2005.02468.x. PMID 15943841...

Hong K, Benz CC (2000). "Emerging antibody-based HER2 (ErbB-2/neu) therapeutics". Breast Disease. 11: 113–124. doi:10.3233/bd-1999-11110. PMID 15687597...

receptor. the interferon (IFN) subfamily. the IL-10 subfamily. The IL-1 family, which primarily includes IL-1 and IL-18. The cysteine knot cytokines (IPR029034)...

March 2019. "[99] Comparative effectiveness of proton pump inhibitors | Therapeutics Initiative". 28 June 2016. Retrieved 14 July 2016. "Dexlansoprazole Use...

gene expression of cytokines including Interleukin 1 (IL-1), IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, and TNF-alpha by binding to corticosteroid response...

"low-affinity" IL-2 receptors are replaced by "high-affinity" IL-2 receptors consisting of α, β, and γ chains. The cell then releases IL-2, which binds...

increases plasma concentrations of buspirone". Clinical Pharmacology and Therapeutics. 64 (6): 655–660. doi:10.1016/S0009-9236(98)90056-X. PMID 9871430. S2CID 22009095...

Magrathea Marble Therapeutics Matter Mistral AI MultiplyLabs N5 Now Nebuly Neumora Neuralink Newcleo Norbert Health Orbital Therapeutics Osmo PhaseV Q Qonto...

have recently entered clinical trials, most notably one from Kymera Therapeutics. Emavusertib (CA-4948) Zimlovisertib (PF-06650833) GRCh38: Ensembl release...